Literature DB >> 11058905

Six novel MEN1 gene mutations in sporadic parathyroid tumors.

F Cetani1, E Pardi, A Giovannetti, P Cerrai, S Borsari, E Vignali, A Picone, L Cianferotti, P Miccoli, A Pinchera, C Marcocci.   

Abstract

We report nine mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in sporadic parathyroid adenomas. Six of them have not previously been described: E60X, P32R, 261delA, 934+2T-->G, S443P, and 1593insC. The tissue samples were initially submitted to LOH analysis at 11q13 followed by SSCP screening of LOH-positive samples. Mutations were identified by direct sequencing and subcloning. Three (E60X, P32R, and 261delA) were in exon 2, one (934+2bp) in the splice junction of exon 5, one (S443P) in exon 9, and one (1593insC) in exon 10. The 3 mutations in exon 2 were associated with loss and/or creation of a restriction site. The corresponding germline sequence of the MEN1 gene was normal. Most mutations would likely result in a nonfunctional menin protein, and therefore in the loss of a tumor suppressor protein. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058905     DOI: 10.1002/1098-1004(200011)16:5<445::AID-HUMU12>3.0.CO;2-6

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors.

Authors:  G Pinna; G Orgiana; C Carcassi; F Alba; F Cetani; E Pardi; C Marcocci; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 2.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

3.  MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; E Vignali; S Borsari; A Picone; L Cianferotti; E Ambrogini; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

4.  Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.

Authors:  Simona Borsari; Elena Pardi; Natalia S Pellegata; Misu Lee; Federica Saponaro; Liborio Torregrossa; Fulvio Basolo; Elena Paltrinieri; Maria Chiara Zatelli; Gabriele Materazzi; Paolo Miccoli; Claudio Marcocci; Filomena Cetani
Journal:  Endocrine       Date:  2016-04-02       Impact factor: 3.633

5.  Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis.

Authors:  Federica Ciregia; Filomena Cetani; Elena Pardi; Alessio Soggiu; Cristian Piras; Lorenzo Zallocco; Simona Borsari; Maurizio Ronci; Vanni Caruso; Claudio Marcocci; Maria Rosa Mazzoni; Antonio Lucacchini; Laura Giusti
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

6.  MEN1 gene mutation with parathyroid carcinoma: first report of a familial case.

Authors:  Luigia Cinque; Angelo Sparaneo; Antonio S Salcuni; Danilo de Martino; Claudia Battista; Francesco Logoluso; Orazio Palumbo; Roberto Cocchi; Evaristo Maiello; Paolo Graziano; Geoffrey N Hendy; David E C Cole; Alfredo Scillitani; Vito Guarnieri
Journal:  Endocr Connect       Date:  2017-11-02       Impact factor: 3.335

7.  Novel association of MEN1 gene mutations with parathyroid carcinoma.

Authors:  Luigia Cinque; Angelo Sparaneo; Filomena Cetani; Michelina Coco; Celeste Clemente; Massimiliano Chetta; Teresa Balsamo; Claudia Battista; Eliana Sanpaolo; Elena Pardi; Leonardo D'Agruma; Claudio Marcocci; Evaristo Maiello; Geoffrey N Hendy; David E C Cole; Alfredo Scillitani; Vito Guarnieri
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

8.  Comprehensive Analysis of MEN1 Mutations and Their Role in Cancer.

Authors:  Devi D Nelakurti; Amrit L Pappula; Swetha Rajasekaran; Wayne O Miles; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2020-09-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.